| Literature DB >> 32447284 |
Anatte Margalit1, James C Carolan1, David Sheehan1, Kevin Kavanagh2.
Abstract
Individuals with cystic fibrosis are susceptible to co-infection by Aspergillus fumigatus and Pseudomonas aeruginosa Despite the persistence of A. fumigatus in the cystic fibrosis lung P. aeruginosa eventually predominates as the primary pathogen. Several factors are likely to facilitate P. aeruginosa colonization in the airways, including alterations to the microbial environment. The cystic fibrosis airways are hypoxic, nitrate-rich environments, and the sputum has higher amino acid concentrations than normal. In this study, significant growth proliferation was observed in P. aeruginosa when the bacteria were exposed to A. fumigatus culture filtrates (CuF) containing a high nitrate content. Proteomic analysis of the A. fumigatus CuF identified a significant number of environment-altering proteases and peptidases. The molecular mechanisms promoting bacterial growth were investigated using label-free quantitative (LFQ) proteomics to compare the proteome of P. aeruginosa grown in the A. fumigatus CuF and in CuF produced by a P. aeruginosa-A. fumigatus co-culture, to that cultured in P. aeruginosa CuF. LFQ proteomics revealed distinct changes in the proteome of P. aeruginosa when cultured in the different CuFs, including increases in the levels of proteins involved in denitrification, stress response, replication, amino acid metabolism and efflux pumps, and a down-regulation of pathways involving ABC transporters. These findings offer novel insights into the complex dynamics that exist between P. aeruginosa and A. fumigatus Understanding the molecular strategies that enable P. aeruginosa to predominate in an environment where A. fumigatus exists is important in the context of therapeutic development to target this pathogen.Entities:
Keywords: Aspergillus; Bacteria; Pseudomonas; cell biology; cystic fibrosis; pathogens; proliferation; secretome
Year: 2020 PMID: 32447284 PMCID: PMC8015003 DOI: 10.1074/mcp.RA120.002059
Source DB: PubMed Journal: Mol Cell Proteomics ISSN: 1535-9476 Impact factor: 5.911
Fig. 1A, Changes in growth of a 24-hour P. aeruginosa culture incubated with sterile Czapek-Dox media (control) or 24-hour, 48-hour, 72-hour or 96-hour A. fumigatus wild-type CuF for 24 h. Maximum growth increase was observed in bacteria exposed to the 48-hour CuF and growth inhibition was observed in bacteria incubated with 96-hour CuF. B, Changes in growth of a 24-hour P. aeruginosa culture incubated in sterile Czapek-Dox media, or 24-hour, 48-hour, 72-hour or 96-hour A. fumigatus ΔgiZ CuF for 24 h. Growth was not inhibited by the 96-hour ΔgliZ CuF.
Fig. 2Growth of Changes in bacterial growth was greatest where P. aeruginosa was exposed to Co-culture CuF. ***: p < 0.001 **: p < 0.01 *: p < 0.05 ns: non-significant.
Fig. 3A, Protein hydrolysate analysis performed on A. fumigatus CuF produced at 48 h detected seven amino acids by RP-HPLC including aspartic acid, glutamic acid, serine, threonine, methionine, valine and leucine. B, P. aeruginosa (24-hour cultures) were exposed to un-supplemented Czapek-Dox or Czapek-Dox supplemented with the seven amino acids detected in the A. fumigatus CuF hyrolysates. P. aeruginosa growth (CFU/ml) increased by 1.6-fold when cultured in amino acid-supplemented Czapek-Dox for 24 h compared with that of bacteria exposed to un-supplemented (- amino acids) Czapek-Dox for 24 h, where growth increased by 1.17-fold.
Fig. 4A, Principal component analysis (PCA) of P. aeruginosa exposed to Co-culture CuF (green) A. fumigatus CuF (orange) and P. aeruginosa CuF (blue). A clear distinction can be observed between each of the groups. B. Clusters based on protein-abundance profile similarities were resolved by hierarchical clustering of multi-sample comparisons between the three sample groups of P. aeruginosa. Nine clusters (A–I) were resolved comprising proteins that display similar expression profiles across treatments. Of these, six clusters (A, C, D, G–I) had statistically enriched Gene Ontology (GO) and KEGG terms associated with them (supplemental Data set S3) and the main terms are summarized for each in C.
Fig. 5Volcano plots derived from pairwise comparisons between The distribution of quantified proteins according to the p value (- log10 p value) and fold change (log2 mean LFQ intensity difference) are shown. Proteins above the line are considered statistically significant (p value <0.05). Protein components of amino acid metabolism (green) and nucleotide biosynthetic process (blue) and response to stress (orange) are more abundant in bacteria cultured in A. fumigatus CuF and Co-culture CuF than in P. aeruginosa CuF. The relative abundance of proteins associated with the periplasmic space and ABC transporters (purple) was decreased in bacteria cultured in A. fumigatus CuF and Co-culture CuF compared with P. aeruginosa CuF. The relative abundance of outer membrane proteins (yellow) was greater in bacteria exposed to A. fumigatus CuF compared with P. aeruginosa CuF and lower in Co-culture CuF compared with A. fumigatus CuF and P. aeruginosa CuF.
Pathways that are most affected by bacterial culture conditions. Differential expression of proteins associated with a stress response and DNA damage repair, respiration and outer membrane proteins in P. aeruginosa: statistically significant proteins and associated relative fold difference arising from pairwise Student's t-tests (p < 0.05) between P. aeruginosa exposed to A. fumigatus CuF and P. aeruginosa CuF, Co-culture CuF and P. aeruginosa CuF and Co-culture CuF and A. fumigatus CuF. A.f.; A. fumigatus CuF, P.a.; P. aeruginosa CuF, Cc; Co-culture CuF. n.s. indicates that the relative fold difference was non-significant
| Pathway | Gene | Protein | Relative fold difference | ||
|---|---|---|---|---|---|
| A.f. v P.a. | Cc v P.a. | Cc v A.f. | |||
| Stress response | xenB | Xenobiotic reductase B | 304.4 | 156 | −1.9 |
| lon | Lon protease | 14.2 | 18.6 | ns | |
| ahpF | Alkyl hydroperoxide reductase subunit F | 20 | 16.5 | ns | |
| cysNC | Bifunctional enzyme CysN/CysC | 15.4 | 13.8 | ns | |
| uvrB | UvrABC system protein B | 15.1 | 12.6 | ns | |
| cysI | Sulfite reductase | 12.2 | 10 | ns | |
| recA | Protein RecA | 5.35 | 7.6 | ns | |
| trxB2 | Thioredoxin reductase | 6.5 | 5.5 | ns | |
| polA | DNA polymerase I | 6.8 | 4.9 | ns | |
| ppx | Exopolyphosphatase | 5.1 | 4.7 | ns | |
| ruvB | Holliday junction ATP-dependent DNA helicase RuvB | 4.5 | 3.5 | ns | |
| katE | Catalase HPII | −6.3 | −13.6 | ns | |
| magD | magD | −3 | −12.2 | ns | |
| cspD | Cold-shock protein CspD | −7.6 | −9.7 | ns | |
| msrB | Peptide methionine sulfoxide reductase | −7 | −5.3 | ns | |
| SenC | SenC | ns | −5 | ns | |
| osmC | Osmotically inducible protein OsmC | −5 | −4.3 | ns | |
| phoB | Phosphate regulon transcriptional regulator | ns | −3.8 | ns | |
| PA0838 | Glutathione peroxidase | −2.1 | −2.3 | ns | |
| gor | Glutathione reductase | −2 | −1.7 | ns | |
| lexA | LexA repressor | −1.4 | −1.6 | ns | |
| Respiration | PA5190 | Probable nitroreductase | 38.8 | 58.5 | 1.5 |
| narG | Respiratory nitrate reductase alpha chain | 30.3 | 53.8 | ns | |
| ccoO2 | Cytochrome c oxidase, cbb3-type, CcoO subunit | 20.53 | 48.5 | 2.4 | |
| moaB1 | Molybdenum cofactor biosynthesis protein B | 21.3 | 43.2 | ns | |
| nosZ | Nitrous-oxide reductase | 20.54 | 39 | ns | |
| hemN | Oxygen-independent coproporphyrinogen-III oxidase | 14.7 | 29.7 | 2 | |
| nirB | Assimilatory nitrite reductase large subunit | 6.6 | 25.6 | 3.9 | |
| narH | Respiratory nitrate reductase beta chain | 9.5 | 19.3 | ns | |
| nirD | Assimilatory nitrite reductase small subunit | Ns | 11.2 | 3.9 | |
| moeA1 | Molybdopterin molybdenum transferase | 5.6 | 8.98 | ns | |
| exaB | Cytochrome c550 | −447.6 | −286.3 | ns | |
| exaA | Quinoprotein alcohol dehydrogenase (cytochrome c) | −13 | −47.6 | −3.7 | |
| PA2171 | Hemerythrin-domain containing protein | −73.9 | −90.5 | ns | |
| napA | Periplasmic nitrate reductase | −7 | −34.8 | −5 | |
| napB | Periplasmic nitrate reductase, electron transfer subunit | −9.9 | −5.83 | ns | |
| bkdB | Lipoamide acyltransferase | −2.7 | −24.1 | −9 | |
| bkdA1 | 2-oxoisovalerate dehydrogenase subunit alpha | Ns | −4.9 | −5.2 | |
| pdhA | Pyruvate dehydrogenase E1 component subunit alpha | −16.4 | −7 | −2.4 | |
| PA3415 | Dihydrolipoamide acetyltransferase | −3.4 | −16.4 | −4.7 | |
| lpdV | Dihydrolipoyl dehydrogenase | −1.9 | 15.4 | −8.2 | |
| Outer membrane | MexE | RND multidrug efflux membrane fusion protein | 132.3 | 47.27 | ns |
| oprC | Outer membrane efflux protein OprC | 38.6 | ns | −15.7 | |
| oprG | Outer membrane protein OprG | 17.3 | 4.9 | −3.5 | |
| oprM | Outer membrane protein OprM | 15 | ns | −16.3 | |
| MexF | Efflux pump membrane transporter | 10.2 | ns | ns | |
| oprE | Anaerobically-induced outer membrane porin OprE | 3.2 | ns | −3.1 | |
| oprJ | Outer membrane protein OprJ | 2.7 | ns | −3.2 | |
| oprO | Porin O | 2.45 | ns | −2.9 | |
| opr86 | Outer membrane protein assembly factor BamA | 2.3 | ns | ns | |
| opmH | Channel protein TolC | 2 | ns | −1.9 | |
| MexC | RND multidrug efflux membrane fusion protein | 1.6 | ns | −3.1 | |
| oprF | Outer membrane porin F | 1.2 | ns | ns | |
| oprQ | Outer membrane protein OprQ | −2.6 | −23.5 | −9.1 | |
| opdQ | Outer membrane porin OpdQ | −2.1 | −13.7 | −6.5 | |
| oprD | Porin D | −9.7 | −5.6 | ns | |
| oprI | Major outer membrane lipoprotein | −6.6 | −3.5 | ns | |
| oprH | PhoP/Q & low Mg2+ inducible outer membrane protein | ns | −3.5 | −3.8 | |
| MexB | Multidrug resistance protein MexB | −2.28 | ns | ns | |